Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
NCT01397461
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
465
Enrollment
INDUSTRY
Sponsor class
Conditions
Impetigo
Interventions
DRUG:
ozenoxacin placebo
DRUG:
retapamulin 1% ointment
DRUG:
ozenoxacin 1% cream
Sponsor
Ferrer Internacional S.A.